Wide-moat GE HealthCare, or GEHC, is a top three global leader in the medical imaging market. It has a firmly established footprint in hospitals and health networks around the world, and it is ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...

BAMF Health’s new charitable foundation received a $100,000 donation from a donor who’s described as a pioneer in molecular ...

Diverse Applications: FAPI-based radiotracers have shown promising results in diagnosing various cancers, particularly gastrointestinal malignancies, and have potential applications in inflammatory ...

This study utilizes bibliometric analysis to investigate the research landscape of FAP-directed cancer theranostics, focusing ...

Radiopharm Theranostics Ltd.’s radiotracer RAD-101 (F18-Pivalate) successfully detected brain metastases in a variety of primary solid tumors in a phase II study.

United Theranostics is a national leader in providing cutting-edge radiopharmaceutical therapy and advanced molecular imaging in a comfortable, patient-centric outpatient setting. The Company is ...

Bold technological advances reign supreme at the University of Cincinnati's 1819 Innovation Hub, as seen by Ohio's latest round of venture ...

United Theranostics closed a $15 million senior debt facility with Old National Bank. The company will use proceeds from the facility to fund ...

Developed under the RUSA (Rashtriya Uchchatar Shiksha Abhiyan) 2.0 and The Bharathiar Cancer Theranostics and Research Center (BCTRC), the four-acre Herbal Garden encompasses 2,000 plants representing ...

The company’s RAD 101 imaging molecule identified brain tumours in all 12 treatment-naïve patients in a proof-of-concept ...

Successful detection of brain metastases using RAD 101 (18F-Pivalate) in a novel multiparametric imaging methodology (PET-mpMRI) study across 22 patients.All brain metastases, regardless of whether th ...